Divisun

Quick links to important sections

Divisun

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Divisun

Property Description
Active Ingredient Colecalciferol (Vitamin D3)
Form Oral Tablet
Pharmacological Class Vitamin D Preparation / Supplement
General Purpose Correcting or Preventing Deficiency
Origin Secosteroid (Synthesized)

What Type of Medicine is Divisun?

Divisun is a single-ingredient oral supplement containing the active component Colecalciferol, which is chemically identical to Vitamin D3. It belongs to the high-level pharmacological class of Vitamin D preparations and is typically sold over-the-counter (OTC). The drug is a single-entity product, meaning it exclusively provides Colecalciferol without combining it with other minerals or compounds.

This focused composition is clinically recognized for its effectiveness in targeted Vitamin D replacement. The vitamin is recognized as an essential nutrient for health. The oral tablet form is engineered for easy and reliable dosing.

What is Divisun Made Of and Where Does it Come From?

Divisun is made of synthesized Colecalciferol, a secosteroid that is structurally identical to the Vitamin D3 your body produces naturally from sunlight. While the active substance is chemically the same as the natural vitamin, the product is manufactured to ensure precise and consistent dosage within the solid tablet base.

Colecalciferol (D3) is a readily usable form of the vitamin for the body, showing effectiveness in maintaining active Vitamin D levels compared to Vitamin D2 (Ergocalciferol).

What is Divisun’s General Purpose?

The general purpose of Divisun is to prevent and correct states of Vitamin D deficiency or insufficiency in the body. This is commonly used in scenarios where exposure to sunlight is limited or dietary intake is insufficient.

By ensuring adequate Vitamin D levels, the medicine supports the body’s ability to efficiently absorb calcium from the diet. This vital process is necessary for maintaining strong bones and teeth. The general benefits of Divisun contribute to overall mineral balance and support normal immune system function.

What side effects are possible with Divisun?

Possible Side Effects and Safety Information

The safety profile of Divisun (Colecalciferol) is governed primarily by its effect on calcium balance. Adverse reactions are officially categorized by the system-organ class affected and the reported frequency in regulatory documents.

Frequency-Classified Adverse Reactions

The most commonly documented side effects are associated with disturbances in the body's mineral levels, as classified in the official regulatory framework:

  • Uncommon (Affects 1 to 10 users in 1,000):
    • Hypercalcaemia (High calcium in the blood)
    • Hypercalciuria (High calcium in the urine)
  • Rare (Affects 1 to 10 users in 10,000):
    • Skin reactions, including rash, pruritus (itching), and urticaria (hives)

Reactions such as severe hypersensitivity (e.g., angio-oedema) have also been documented, though their frequency is currently not known.


Serious Risks and Safety Restrictions

The primary serious risk documented in regulatory labeling is Hypervitaminosis D (Vitamin D toxicity) resulting from cumulative, excessive intake. This condition can lead to severe and sustained hypercalcaemia, which is associated with the potential for irreversible renal impairment (kidney damage).

Divisun is strictly contraindicated and should not be used in individuals with pre-existing conditions related to elevated calcium levels or kidney function, including Hypercalcaemia, Hypercalciuria, Nephrolithiasis (kidney stones), and severe renal impairment.

Official documents also advise caution and monitoring for specific populations, such as patients with sarcoidosis or pre-existing renal impairment, as well as patients concurrently using certain medications, including cardiac glycosides or thiazide diuretics.

Overdose and Emergency Response

Documented Overdose Manifestations

The official regulatory profile for Divisun (Colecalciferol) overdose centers on a condition known as Hypervitaminosis D, which causes dangerously elevated levels of calcium in the blood (Hypercalcaemia) and urine (Hypercalciuria). Manifestations of toxicity often begin with gastrointestinal symptoms such as nausea, vomiting, constipation, and abdominal pain. Systemic effects include significant thirst (polydipsia), excessive or frequent urination (polyuria), muscle weakness, and fatigue. These signs are explicitly documented in official prescribing information as indicators of potential overdose.

Severe Systemic Outcomes

When hypercalcaemia becomes severe, official labeling warns of life-threatening effects. These documented outcomes include damage to the renal system (e.g., nephrocalcinosis and potential kidney failure), complications in the cardiovascular system (e.g., cardiac arrhythmias and vascular calcification), and central nervous system effects such as stupor or coma. Overdose during pregnancy is specifically noted due to the documented risk of physical and mental disability in the fetus.

Seeking Urgent Medical Help

Regulators mandate that if overdose is suspected or confirmed by symptoms, the Divisun product and any co-administered calcium supplements must be discontinued immediately. Urgent medical attention is required for symptomatic or laboratory-confirmed cases. Management procedures focus entirely on supportive measures, including rehydration and pharmacological interventions to lower serum calcium, as no specific antidote is known.

Therapeutic Uses of Divisun

What Divisun Treats: Main Uses and Benefits

Divisun (cholecalciferol) is applied across therapeutic domains where additional symptomatic support is needed to manage the manifestations of Vitamin D deficiency. It is commonly used for conditions presenting with symptoms related to systemic imbalance, including those that affect bone and muscle function.

The medication is indicated for conditions presenting with systemic or localized discomfort related to bone disorders, including rickets and osteomalacia.

Supportive Relief and Stability

This medication helps address symptom clusters that create noticeable physiological strain, particularly during phases when symptoms become more noticeable. It contributes to improved comfort during periods of heightened symptoms, and is relevant when symptoms interfere with daily functioning. In clinical scenarios involving temporary physiological imbalance, Divisun supports the patient during difficult episodes by helping to maintain a sense of stability when symptoms are more noticeable.


Quick Fact: Relevant for Musculoskeletal Discomfort

Regulatory References

  1. NIH MedlinePlus overview of Cholecalciferol

Eligibility and Restrictions for Use

The official regulatory profile for Divisun (Colecalciferol) establishes specific conditions under which use is either prohibited or requires strict medical caution. The core non-eligibility rules are centered on the body’s existing calcium balance and renal (kidney) function.

Eligibility Status Populations / Conditions
Contraindicated (Must Not Use) Patients with hypercalcaemia (high blood calcium), hypercalciuria (high urine calcium), hypervitaminosis D, and severe renal impairment. Use is also prohibited in those with nephrolithiasis (kidney stones) or nephrocalcinosis.
Conditional Use (Caution Required) Sarcoidosis requires close monitoring due to altered metabolism. Patients with non-severe renal impairment or a tendency to form kidney stones must have their calcium and phosphate levels checked regularly.
Age-Related Status Use is generally established in adults. Specific high-dose formulations are not recommended for children and adolescents under 18 years.
Lifecycle Restriction High-dose use is not recommended during pregnancy or lactation to avoid excessive exposure to the fetus or infant.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documentation for Divisun (Colecalciferol) outlines several types of interactions, primarily focusing on managing calcium levels and ensuring adequate drug exposure. Co-administration with other Vitamin D analogues or metabolites is formally classified as a contraindicated combination due to the significantly increased risk of hypercalcaemia.

Documented Pharmacokinetic Interactions

Medicines that induce hepatic enzymes, such as certain anticonvulsants (e.g., phenytoin) and tuberculosis agents (e.g., rifampicin), are documented to increase the metabolism of Colecalciferol, which can officially reduce its therapeutic effect. Similarly, agents that impair fat absorption—including ion exchange resins (e.g., cholestyramine), the lipase inhibitor Orlistat, and liquid paraffin—may reduce the gastrointestinal absorption of Colecalciferol. The label specifies that Divisun should not be taken within two hours of Orlistat.

Documented Pharmacodynamic Interactions

Co-administration with thiazide diuretics may lead to an increased risk of hypercalcaemia due to reduced urinary calcium excretion. Furthermore, if hypercalcaemia occurs, the risk of digitalis toxicity with co-administered cardiac glycosides (e.g., digoxin) is increased. Glucocorticoid steroids are noted to increase Colecalciferol metabolism and elimination, requiring caution. Population-specific cautions are noted for patients with sarcoidosis and those with severe renal impairment.

Mechanism of Action

How Divisun Works

Divisun contains colecalciferol (Vitamin D3), which acts as a prohormone and is metabolized in the liver and kidneys to its active form, calcitriol (1,25-dihydroxycholecalciferol). Calcitriol is the ligand for the Vitamin D Receptor (VDR), a nuclear transcription factor, which mediates the drug's primary effects.


Transcriptional Modulation via VDR Engagement

Calcitriol acts within the domain of receptor-mediated signaling by binding to the widespread Vitamin D Receptor (VDR), which is present in various tissues. This VDR-ligand complex modulates the transcription of hundreds of genes. This gene-regulatory mechanism initiates signaling cascades that influence mineral and skeletal regulatory pathways.


Regulation of Calcium and Phosphate Pathway Activity

The key pathway effect involves the modulation of mineral absorption and reabsorption in the intestines and kidneys, respectively. This action influences the modulation of serum calcium and phosphate levels, a physiological adjustment preceding effects on bone turnover. It also engages mechanisms that influence the feedback regulation of parathyroid hormone (PTH), impacting the dynamic equilibrium of mineral status.

Dosage and Administration Information

How to Use Divisun

Divisun (colecalciferol) administration involves the oral route, following standard dosing ranges and specific conditions for intake.


Administration Scope

The medicine is designed as an Oral Tablet and is to be taken by mouth. The typical regimen is once daily, with dosages ranging from a maintenance level of 800 IU up to a higher dose of 4000 IU daily for the initial correction of established deficiency, as determined by the prescribing authority. To ensure optimal absorption, the tablet can be taken with food, often alongside the main meal. Patients may swallow the tablet whole or crush it if required for easier intake.


Dosing and Procedural Constraints

The product is generally not recommended for use in children under 12 years due to a lack of established safety and efficacy data for this age group. For individuals with hepatic impairment, no dose adjustment is typically required. However, in cases of severe renal insufficiency, the use of colecalciferol requires caution, as alternative Vitamin D forms may be necessary.

During long-term therapy, the regular monitoring of the patient’s serum calcium levels and renal function is necessary to ensure continued appropriate use. If a dose is missed, it should be skipped if the next dose is due soon; it is important that a double dose must not be taken to compensate. This procedural framework ensures the standardized and controlled administration of the medicine.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Phase 3 Clinical Trials

Research has examined whether combining Drug A and Drug B is an option for managing moderate to severe pain. Clinical trials evaluated the product's effect on pain intensity.

Multiple clinical studies compared the combination product to Drug A and Drug B used alone. The clinical trials also evaluated the change in pain intensity score at the 12-hour mark.

These trials were designed as randomized, double-blind studies involving 1,500 participants with chronic pain. The study design specified the primary measure as the change in pain intensity score from baseline at the 12-hour mark.


Safety and Tolerability Profile

The clinical trials evaluated the product's safety profile; the most common adverse events were recorded. Adverse events observed were generally aligned with the known profiles of Drug A and Drug B.

Studies defined a history of heart problems as an exclusion criterion for participation.

Frequently Asked Questions (FAQ)

Common questions about Divisun (FAQ)


Q: What is the main reason Divisun is prescribed?

A: According to official product information, the primary purpose of Divisun (Colecalciferol) is the prevention and correction of Vitamin D deficiency or insufficiency in the body. The medicine is used to restore adequate levels of this essential nutrient, which is vital for mineral balance.


Q: Is Divisun safe to use if I have kidney issues?

A: Regulatory documents state that Divisun is contraindicated (meaning it should not be used) in cases of severe renal impairment (severe kidney issues). In cases of non-severe kidney impairment, official documents indicate that the use of Divisun necessitates caution, and procedures often involve regular monitoring of calcium and kidney function.


Q: What are the official guidelines regarding Divisun use during pregnancy?

A: Official restrictions state that high-dose use is not recommended during pregnancy or lactation to avoid excessive exposure to the fetus or infant. However, the need for treatment due to a confirmed Vitamin D deficiency remains a possibility that would be assessed by a healthcare professional.


Q: Is Divisun safe for older adults or the elderly population?

A: Regulatory assessments have noted that Vitamin D insufficiency is widespread in the elderly population. Studies have examined the combination of Vitamin D and calcium, finding that it may be relevant for improving balance and muscle function in older adults.


Q: Is Divisun the same as regular Vitamin D supplements?

A: Divisun contains the active ingredient Colecalciferol (Vitamin D3), which is structurally identical to the vitamin your body produces naturally. It is officially classified as a Vitamin D Preparation/Supplement and is typically used to support the management of diagnosed deficiency or insufficiency.


Q: Is Divisun used for anything other than bone health?

A: The medicine's main official purpose is tied to mineral balance and supporting bone and teeth health through calcium absorption. Regulatory documents also describe the general benefits of Colecalciferol as supporting normal immune system function.


Q: What happens if I miss a dose of Divisun?

A: Regulatory guidelines state that if a dose is missed, it should be skipped if the next scheduled dose is due soon. It is specifically stated that a double dose must not be taken to compensate for the missed dose.


Q: Do you have to take Divisun with food or can it be taken alone?

A: Regulatory documents advise that the tablet can be taken with food, often alongside the main meal. This recommendation is given to help ensure optimal absorption of the medicine in the body.


Q: Can Divisun affect my blood pressure readings?

A: Official drug documents do not list an effect on blood pressure readings as a known side effect. However, some studies have examined Vitamin D's role in body systems that are involved in blood pressure control.


Q: Are there any specific vitamins or minerals that Divisun should not be taken with?

A: Regulatory summaries indicate that co-administration with other vitamin or mineral supplements containing calcium or Vitamin D may increase the risk of elevated calcium levels, and should be discussed with a healthcare professional.


Q: Can Divisun be used by children, and if so, at what age?

A: Divisun is generally established for use in adults. The product is often not recommended for use in children under 12 years due to a lack of established safety and efficacy data for that age group. High-dose formulations are officially not recommended for adolescents under 18 years.


Q: How is the benefit of Divisun typically measured?

A: The effect of long-term therapy is assessed through regular monitoring of the patient’s serum calcium levels and renal function. The main indicator used by practitioners to assess Vitamin D status is the blood level of 25-hydroxyvitamin D (25-OH-D).


Q: Is Divisun a steroid or a hormone?

A: Divisun contains Colecalciferol, which is chemically defined as a secosteroid. It is metabolized in the body into calcitriol, which acts as a prohormone. The active form is described as a hormone required for the body to absorb calcium.


Q: How long does Divisun stay in your system after stopping treatment?

A: Pharmacokinetic studies, which describe how the body handles the medicine, indicate that the main storage metabolite of Colecalciferol has a slow turnover. This metabolite, called 25-hydroxyvitamin D (calcidiol), has an estimated half-life of approximately 15 days.


Q: Why do some people take Divisun daily while others take it weekly or monthly?

A: While the standard regimen is often described as once daily, the medicine's long half-life allows for less-frequent, higher-dose regimens (e.g., weekly or monthly) to treat deficiency. The specific schedule is based on the determination of the prescribing authority.


Q: Does Divisun affect liver function tests?

A: While dose adjustment is typically not required for hepatic impairment (liver issues), official information indicates that liver disease can be associated with low Vitamin D levels due to impaired synthesis or absorption. In such cases, the monitoring of Vitamin D levels may be a consideration.


Q: Is Divisun addictive or habit-forming?

A: Regulatory documents do not classify Divisun (Colecalciferol), a Vitamin D preparation, as an addictive or habit-forming substance. This product is classified as an essential nutrient and prohormone.


Q: Does Divisun interact with herbal or natural supplements?

A: Regulatory guidance advises caution in this area. It notes that information may be insufficient regarding the potential for interactions between Colecalciferol and most complementary medicines, herbal remedies, and supplements.


Q: How does Divisun's effect compare to getting sun exposure?

A: The active substance in Divisun is synthesized Colecalciferol, which is structurally identical to the Vitamin D3 your body produces naturally from sunlight exposure. The purpose of the medicine is to provide a precise, measured dose when sun exposure or diet is insufficient.


Q: Does Divisun cause changes to hair or skin?

A: Official documents list rare side effects that include skin reactions such as rash, pruritus (itching), and urticaria (hives). These reactions are associated with the medication's safety profile, but changes to hair texture are not listed.


Q: Why is my doctor prescribing Divisun if my blood test was only slightly low?

A: Official clinical guidelines often define specific levels, such as mild deficiency (e.g., 30–49 nmol/L), that warrant treatment. Prescribers follow these defined protocols to restore Vitamin D levels to the target range deemed optimal for health.


Q: What does the official research evidence say about Divisun's long-term use?

A: Official procedural guidelines indicate that regular monitoring of serum calcium and renal function is a consideration during long-term therapy. Regulatory bodies often cite a tolerable upper intake level (UL) for daily intake that is not expected to pose health risks when taken over the long term.

How should Divisun be stored and disposed of?

How to Store and Dispose of Divisun?

Official regulatory documents define strict conditions for the storage and disposal of Divisun (colecalciferol) tablets.


Storage Requirements

The product must be stored at Controlled Room Temperature, typically 20 C to 25 C (68 F to 77 F), and must not be stored above 30 C or subjected to freezing. To maintain stability, the tablets must be kept in the original container, which should be tightly closed to protect from moisture and light. Always store the medicine out of the sight and reach of children.


Disposal Instructions

Unused or expired Divisun must be disposed of in accordance with local requirements for pharmaceutical waste. Do not discard this medicine in household trash or wastewater. Consult a pharmacist or healthcare professional for guidance on proper disposal procedures.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Divisun found in:

A-Z Index: